Health TrialsbyHealthPanel

Methamphetamine, PrEP, and Intersectional Stigma Study

ConditionsMethamphetamine AbuseHivSocial Stigma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorArizona State University

About this trial

The goal of this clinical trail is to test the developed eMPrISe study in HIV-negative, adult, Latino men who have sex with men (MSM) who use non-injection substances. The main questions it aims to answer are:

* Can participation in the developed eMPrISe study reduce methamphetamine ('meth') use risk? * Can participation in the developed eMPrISe study improve preexposure prophylaxis (PrEP) cascade progression? Participants will participate in 12 weekly modules that: (1) build critical thinking skills, (2) identify and discuss the link between oppression and harmful behaviors, (3) take action, (4) voice and validate feelings and experiences, and (5) share knowledge and resources.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18+ years of age

cisgender male

self-identify as Latino or Hispanic

fluent in English or Spanish

Disqualifiers

N/A

Trial design

Design model

Parallel

Treatments tested in this trial

  • Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study

    Behavioral

    Group behavioral intervention with 12 weekly sessions lasting 2 hours focusing on coping, resistance, and resilience.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: EnglishOther 1 intervention
Group B: SpanishOther 1 intervention

Trial outcomes

Primary outcomes

1

Methamphetamine use risk

Assessed using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Scores range from 0 - 39, where higher scores indicate higher risk.

Time frame
3 Months
2

PrEP cascade progression

Assessed using the Motivational PrEP Cascade Ordinal outcome including: 1= PrEP pre-contemplation, 2= PrEP contemplation, 3=PrEParation, 4=PrEP Action \& Initiation, 5=PrEP Maintenance

Time frame
3 Months

Secondary outcomes

1

Resistance

Assessed using items adapted from the Stigma Resistance Scale Scores range from 0 - 76, where higher scores indicate higher levels of resistance

Time frame
3 Month
2

Resilience

Assessed using items from the Connor-Davidson Resilience Scale (CD-RISC) Scores range from 0-40, where higher scores indicate higher levels of resilience

Time frame
3 Month
3

Coping

Assessed using the Coping Inventory for Stressful Situations (CISS) Scores range from 0-84, where higher scores indicate higher levels of coping

Time frame
3 Month

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Arizona State University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: